The effects of cholecystokinin on dopaminergic mechanisms in rat striatum
- 31 October 1983
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 277 (2) , 375-376
- https://doi.org/10.1016/0006-8993(83)90949-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The ascent of cholecystokinin (CCK) — From gut to brainLife Sciences, 1982
- Modulation by cholecystokinins of 3H‐spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sitesActa Physiologica Scandinavica, 1981
- Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- VI. The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detectionLife Sciences, 1981
- Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in miceEuropean Journal of Pharmacology, 1981
- Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injectionEuropean Journal of Pharmacology, 1980
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980
- Spiperone: A ligand of choice for neuroleptic receptorsBiochemical Pharmacology, 1978